Medindia LOGIN REGISTER
Medindia

Side effect(s) of Elotuzumab


Review the side-effects of Elotuzumab as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Gastrointestinal:
Loose stools, decreased appetite, constipation, vomiting

  Nervous system:
Headache, fever, abnormal tiredness, dizziness or lightheadedness, weight loss, burning or numbness of the hands and feet, mood alterations

  Blood:
Heart rate abnormalities, fluctuations in blood pressure

  Respiratory:
Cough, lung infection, chest pain, sore throat, shortness of breath

  Lab abnormalities:
Low levels of lymphocytes, platelets, white blood cells, calcium, bicarbonate and albumin, high levels of blood sugar, blood potassium and liver enzymes

  Others:
Vision changes, night sweats, skin tags, dark urine and pale stools

Other Precautions :

• Women of childbearing age should check their pregnancy status twice, initially 15 days and 24 hours before starting lenalidomide. Treatment should be initiated only if the tests show a negative result. Pregnancy testing should be done every four weeks in women with regular menstrual cycles.

• Women should take effective contraception four weeks before starting lenalidomide therapy, during the treatment, and four weeks after the discontinuation of the lenalidomide therapy.

Lenalidomide is found in the semen and men living with an active female partner should use condoms to avoid pregnancy. Men should not donate sperms during lenalidomide treatment for at least 28 days after the last dose of lenalidomide.

Drug Name : Elotuzumab

Elotuzumab injection is used to treat a type of bone marrow cancer (multiple myeloma) along with lenalidomide and dexamethasone in patients whose cancer has returned after successful treatment or in patients who failed to respond to one to three cancer-treating drugs.


Advertisement